TGFB1 and neoplasm: This suppression primarily occurs through the release of inhibitory cytokines, including TGF-β, IL-10 and IL-35, which dampen effector T-cell functions, thus reducing the activation, proliferation and cytokine production of the CAR T cells that manage to infiltrate the tumour [34,73,74].